These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 19411110)
1. Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase. Paixão-Cavalcante D; Hanson S; Botto M; Cook HT; Pickering MC Mol Immunol; 2009 Jun; 46(10):1942-50. PubMed ID: 19411110 [TBL] [Abstract][Full Text] [Related]
2. Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice. Fakhouri F; de Jorge EG; Brune F; Azam P; Cook HT; Pickering MC Kidney Int; 2010 Aug; 78(3):279-86. PubMed ID: 20445496 [TBL] [Abstract][Full Text] [Related]
3. Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice. Rose KL; Paixao-Cavalcante D; Fish J; Manderson AP; Malik TH; Bygrave AE; Lin T; Sacks SH; Walport MJ; Cook HT; Botto M; Pickering MC J Clin Invest; 2008 Feb; 118(2):608-18. PubMed ID: 18202746 [TBL] [Abstract][Full Text] [Related]
4. C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo. Ruseva MM; Takahashi M; Fujita T; Pickering MC Clin Exp Immunol; 2014 Apr; 176(1):84-92. PubMed ID: 24279761 [TBL] [Abstract][Full Text] [Related]
5. Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency. Ruseva MM; Vernon KA; Lesher AM; Schwaeble WJ; Ali YM; Botto M; Cook T; Song W; Stover CM; Pickering MC J Am Soc Nephrol; 2013 Jan; 24(1):43-52. PubMed ID: 23184055 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy. Ruseva MM; Peng T; Lasaro MA; Bouchard K; Liu-Chen S; Sun F; Yu ZX; Marozsan A; Wang Y; Pickering MC J Am Soc Nephrol; 2016 Feb; 27(2):405-16. PubMed ID: 26047789 [TBL] [Abstract][Full Text] [Related]
8. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Pickering MC; Cook HT; Warren J; Bygrave AE; Moss J; Walport MJ; Botto M Nat Genet; 2002 Aug; 31(4):424-8. PubMed ID: 12091909 [TBL] [Abstract][Full Text] [Related]
9. Distinct and separable roles of the complement system in factor H-deficient bone marrow chimeric mice with immune complex disease. Alexander JJ; Aneziokoro OG; Chang A; Hack BK; Markaryan A; Jacob A; Luo R; Thirman M; Haas M; Quigg RJ J Am Soc Nephrol; 2006 May; 17(5):1354-61. PubMed ID: 16597679 [TBL] [Abstract][Full Text] [Related]
10. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin. Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880 [TBL] [Abstract][Full Text] [Related]
11. Podocytes Produce and Secrete Functional Complement C3 and Complement Factor H. Mühlig AK; Keir LS; Abt JC; Heidelbach HS; Horton R; Welsh GI; Meyer-Schwesinger C; Licht C; Coward RJ; Fester L; Saleem MA; Oh J Front Immunol; 2020; 11():1833. PubMed ID: 32922395 [TBL] [Abstract][Full Text] [Related]
12. Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Pickering MC; Warren J; Rose KL; Carlucci F; Wang Y; Walport MJ; Cook HT; Botto M Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9649-54. PubMed ID: 16769899 [TBL] [Abstract][Full Text] [Related]
13. Complement Receptor 2 Based Immunoassay Measuring Activation of the Complement System at C3-Level in Plasma Samples From Mice and Humans. Halkjær L; Troldborg A; Pedersen H; Jensen L; Hansen AG; Hansen TK; Bjerre M; Østergaard JA; Thiel S Front Immunol; 2020; 11():774. PubMed ID: 32431705 [TBL] [Abstract][Full Text] [Related]
14. C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice. Zhang Y; Keenan A; Dai DF; May KS; Anderson EE; Lindorfer MA; Henrich JB; Pitcher GR; Taylor RP; Smith RJ JCI Insight; 2020 May; 5(9):. PubMed ID: 32376801 [TBL] [Abstract][Full Text] [Related]
16. Properdin binds independent of complement activation in an in vivo model of anti-glomerular basement membrane disease. O'Flynn J; Kotimaa J; Faber-Krol R; Koekkoek K; Klar-Mohamad N; Koudijs A; Schwaeble WJ; Stover C; Daha MR; van Kooten C Kidney Int; 2018 Dec; 94(6):1141-1150. PubMed ID: 30322716 [TBL] [Abstract][Full Text] [Related]
17. Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation. Borza DB Matrix Biol; 2017 Jan; 57-58():299-310. PubMed ID: 27609404 [TBL] [Abstract][Full Text] [Related]
18. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3. Newman SL; Mikus LK J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200 [TBL] [Abstract][Full Text] [Related]
19. An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy. Yang Y; Denton H; Davies OR; Smith-Jackson K; Kerr H; Herbert AP; Barlow PN; Pickering MC; Marchbank KJ J Am Soc Nephrol; 2018 Jun; 29(6):1649-1661. PubMed ID: 29588430 [No Abstract] [Full Text] [Related]